The Risks of an Ownership Society

Swartz, Katherine
December 2004
Inquiry (00469580);Winter2004/2005, Vol. 41 Issue 4, p357
Academic Journal
Comments on the rising cost of medical care in the U.S. Association of the ownership society with the desire of employers to reduce their role in the system of health insurance; Importance of the Medicare Modernization Act for an individual's health savings account (HSA); Contributions of employers to HSA.


Related Articles

  • Drug Coverage, Utilization, and Spending by Medicare Beneficiaries with Heart Disease. Sharma, Ravi; Hongji Liu, Ravi; Yinghua Wang, Ravi // Health Care Financing Review;Spring2003, Vol. 24 Issue 3, p139 

    For Medicare beneficiaries who report having heart disease, drug coverage and type of supplemental health insurance affect the likelihood of usage and costs of heart medications, but not the extent of usage. Nearly one in five does not use heart medications and of the latter, one-third lack drug...

  • Skilled Nursing Facilities: Medicare Payment Changes Require Provider Adjustments But Maintain Access: HEHS-00-23.  // GAO Reports;12/14/1999, p1 

    In 1998, Medicare began the transition to a prospective payment system for skilled nursing facility services provided to Medicare beneficiaries. Medicare began paying fixed, preset rates for each day of care?a major change from the former system of cost-based reimbursement. GAO found that the...

  • Medicaid Fraud and Abuse: CMS's Commitment to Helping States Safeguard Program Dollars Is Limited: GAO-05-855T. Aronovitz, Leslie G. // GAO Reports;6/28/2005, p1 

    Today's hearing addresses fraud and abuse control in Medicaid, a program that provides health care coverage for eligible low-income individuals and is jointly financed by the federal government and the states. In fiscal year 2003, Medicaid covered nearly 54 million people and the program's...

  • Medicare, Medicaid spur generics prospects. Frederick, James // Drug Store News;9/25/2006, Vol. 28 Issue 12, p40 

    The article reports on the projected increase in sales of generic drugs triggered by the two biggest health care purchasers in the U.S. in 2007. To contain soaring costs of health care expenses, health care agencies are resorting to generic drugs to increase state savings by instituting...

  • The Potential For Cost Savings In Medicare's Future. Cutler, David M. // Health Affairs;2005 Web-Exclusive Supplement 2, Vol. 24, pR77 

    The papers in this special Health Affairs collection offer a fresh and very important look at Medicare's future. Taken as a whole, they suggest that financing problems in Medicare will be particularly acute in coming decades. Other pieces of evidence suggest that this outlook is not as...

  • Health Spending Projections Through 2017: The Baby-Boom Generation Is Coming To Medicare. Keehan, Sean; Sisko, Andrea; Truffer, Christopher; Smith, Sheila; Cowan, Cathy; Poisal, John; Clemens, M. Kent // Health Affairs;2008 Supplement, Vol. 27 Issue 1/2, pw145 

    The outlook for national health spending calls for continued steady growth. Spending growth is projected to be 6.7 percent in 2007, similar to its rate in 2006. Average annual growth over the projection period is expected to be 6.7 percent. Slower growth in private spending toward the end of the...

  • THE COMMITTEE ON GOVERNANCE CORNER. Dyrstad, Joanell // Trustee;Nov/Dec2007, Vol. 60 Issue 10, p6 

    The article focuses on the efforts of the American Hospital Association (AHA) to demonstrate to the U.S. Congress that budgetary cuts in Medicare and Medicaid programs are harmful. Report says that AHA and others have successfully advocated to place a moratorium on a Centers for Medicare &...

  • Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors. Fischer, Michael A.; Schneeweiss, Sebastian; Avorn, Jerry; Solomon, Daniel H. // New England Journal of Medicine;11/18/2004, Vol. 351 Issue 21, p2187 

    Background: Over the past five years, selective cyclooxygenase-2 inhibitors (coxibs) have accounted for a growing proportion of prescriptions for nonsteroidal antiinflammatory drugs (NSAIDs). To control these expenses, many state Medicaid programs have implemented prior-authorization...

  • Nothing for something? Estimating cost and value for beneficiaries from recent medicare spending increases on HMO payments and drug benefits. Pizer, Steven; Frakt, Austin; Feldman, Roger // International Journal of Health Care Finance & Economics;Mar2009, Vol. 9 Issue 1, p59 

    The Medicare Modernization Act of 2003 added a new outpatient prescription drug benefit to Medicare and increased payments to HMOs. We estimate a nested logit model of plan choice to quantify the welfare benefits from these two expansion paths. We find that the addition of stand-alone...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics